Has Nidhi Narayan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,410 in general payments to Nidhi Narayan, MD across 909 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nidhi Narayan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nidhi Narayan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nidhi Narayan, MD

Endocrinology, Diabetes & Metabolism · Harrington Park, NJNPI 1609073386

Payments from drug & device makers

$13,410in general payments, 2019–2025

Across 909 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$3K
Novo Nordisk$2K
Lilly USA, LLC$2K
Corcept Therapeutics$1K
AstraZeneca$693
Boehringer Ingelheim$546
plus $5K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	223	$2,807
Novo Nordisk	138	$1,794
Lilly USA, LLC	117	$1,524
Corcept Therapeutics	48	$1,029
AstraZeneca(2 entities)	45	$693
Boehringer Ingelheim	44	$546
Amneal Pharmaceuticals LLC	36	$516
Sanofi-aventis U.S. LLC	27	$503
Merck	34	$467
AbbVie	21	$293
Medtronic	6	$276
Bayer	10	$261
GSK	10	$258
Mannkind Corporation	13	$240
Johnson & Johnson(2 entities)	12	$198
Shire North American Group Inc	9	$192
Xeris Pharmaceuticals, Inc.	11	$186
Abbott	9	$155
Amarin Pharma, Inc.	11	$151
Insulet Corporation	7	$131
Kowa Pharmaceuticals America, Inc.	8	$114
Harmony Biosciences LLC	7	$99
Tolmar, Inc.	5	$85
Eisai Inc.	5	$71
Jazz Pharmaceuticals Inc.	5	$71
IBSA Pharma Inc.	4	$68
Exact Sciences	2	$63
Antares Pharma, Inc.	4	$61
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$57
Endo Pharmaceuticals Inc.	3	$43
Amphastar Pharmaceuticals, Inc.	2	$32
Dexcom, Inc.	2	$32
Clarus Therapeutics Inc.	2	$29
BD	2	$27
Takeda Pharmaceuticals U.S.A., Inc.	2	$27
Acerus Pharmaceuticals Corporation	2	$26
Senseonics, Incorporated	1	$20
Lundbeck LLC	1	$17
Mayne Pharma Commercial LLC	1	$17
Ascendis Pharma Endocrinology Inc	1	$17
Otsuka America Pharmaceutical, Inc.	1	$16
Verity Pharmaceuticals Inc.	1	$16
Recordati_rare_diseases_inc.	1	$16
Bausch Health US, LLC	1	$15
Zealand Pharma US, Inc.	1	$15
Braintree Laboratories, Inc.	1	$15
Sun Pharmaceutical Industries Inc.	1	$15
Currax Pharmaceuticals LLC	1	$14
Alfasigma USA, Inc.	1	$14
Novartis	1	$14
Astellas Pharma US Inc	1	$13
Scilex Pharmaceuticals Inc.	1	$13
Ultragenyx Pharmaceutical Inc.	1	$13
Pfizer	1	$13
Aytu Biopharma, Inc.	1	$11

How this compares

$13,410 in reported general payments places this provider in the 85th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Medicare billing

Part B allowed, 2024

$124,915

Medicare patients

282

Services billed

2,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Harrington Park

Barry GertzRahway$903K
Nawras MakhsidaRandolph$882K
Marc SandbergFlemington$567K
Joanne WaldstreicherNew Brunswick$441K
Gregory BaroneCherry Hill$433K
Taher ModarressiPennington$414K
Navtika DesaiHillsborough$408K
Atara SchultzTeaneck$357K
Anthony CannonTurnersville$296K
Sunil AsnaniBrick$295K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →